Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Raises Outlook for Accelerated Revenue and Earnings per Share Growth in Fiscal 2021


GlobeNewswire Inc | May 12, 2021 04:01PM EDT

May 12, 2021

Raises Outlook for Accelerated Revenue and Earnings per Share Growth in Fiscal 2021

Solidifies Cloud Domain Leadership with Acquisition of Sourced Group

SecondQuarter Fiscal 2021Highlights

-- Revenue of $1,049 million, above the midpoint of the $1,015-$1,055 million guidance range; revenue included a negative impact from foreign currency movements of approximately $1 million compared to our guidance assumptions -- Record managed services revenue of $635 million, equivalent to approximately 61% of total revenue -- GAAP diluted EPS of $0.91, at the midpoint of the $0.87-$0.95 guidance range -- Non-GAAP diluted EPS of $1.13, above the midpoint of the $1.09-$1.15 guidance range -- GAAP operating income of $149 million; GAAP operating margin of 14.2% -- Non-GAAP operating income of $185 million; increased non-GAAP operating margin of 17.6% -- Returned record quarterly cash amount of $403 million to shareholders through share repurchases and quarterly cash dividends, including net proceeds received from the divestiture of OpenMarket -- Quarterly free cash flow of $70 million, comprised of cash flow from operations of $120 million, less $49 million in net capital expenditures and other(1) -- Normalized free cash flow of $133 million(1) -- Twelve-month backlog of $3.54 billion up approximately $50 million sequentially; on a pro forma(2) basis, record twelve-month backlog was up 9.3% as compared to last years second fiscal quarter -- The board of directors approved a quarterly cash dividend of $0.36 per share to be paid on July 23, 2021

ST. LOUIS, May 12, 2021 (GLOBE NEWSWIRE) -- Amdocs Limited (NASDAQ: DOX) today reported operating results for the three months ended March 31, 2021.

I am pleased to report strong results for the second fiscal quarter. Revenue was well above the midpoint of guidance and driven by our best-ever quarter in North America on a pro forma(2) basis where we are seeing healthy activity levels at AT&T, T-Mobile and various other customers across the region. At the operating level, we maintained our focus on consistent project delivery, which translated to healthy cash collections and robust free cash flow generation. Additionally, we returned a record cash amount of more than $400 million to shareholders this quarter, including the net proceeds received from the divesture of OpenMarket, as we had committed to previously, said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.

Sheffer continued, Accelerating the communications industrys journey to the cloud is core to Amdocs future growth and this quarter we took some important steps to further solidify our leadership in this domain. We are today pleased to announce the acquisition of Sourced Group, a leading global technology consultancy specializing in large-scale cloud transformations for sophisticated, high-end enterprise customers in different industries such as communications, financial services and others. Sourceds proven cloud migration platform, deployment framework and trusted design process, alongside its deep partnerships with Amazon Web Services, Microsoft Azure and Google Cloud Platform, complement our portfolio of cloud-native products and services and further expands and diversifies our customer base.

Sheffer concluded, I am pleased to report an improved outlook for revenue and earnings per share growth for the full fiscal year 2021, mainly driven by our expectation for a stronger second half. Our confidence is based on the visibility of our 12-month backlog, which is up more than 9% from a year ago on a pro forma(2) basis. Moreover, we are focused on maintaining our recent sales momentum by executing our growth strategy which we believe is well-aligned with our customers multi-year investments in digital modernization, 5G, cloud migration, and next-generation OSS platforms.

Revenue

Revenue for the second fiscal quarter ended March 31, 2021 was $1,049 million, which on a pro forma basis(2) was up 5.7% in constant currency as compared to last years second fiscal quarter. Revenue was down $37 million as reported from the first fiscal quarter of 2021, mainly reflecting the divestiture of OpenMarket on December 31, 2020. Revenue was up 0.1% as reported and down 1.4% in constant currency as compared to last years second fiscal quarter. Revenue for the second fiscal quarter of 2021 includes a positive impact from foreign currency movements of approximately $3.3 million relative to the first quarter of fiscal 2021. Revenue was above the midpoint of Amdocs guidance, and included negative impact from foreign currency movements of approximately $1 million compared to our guidance assumptions and contributions from recently completed acquisitions of less than $2 million which was not included in our guidance assumptions. Revenue for the second fiscal quarter of 2021 includes record managed services revenue of $635 million, up 5.1% as compared to last years second fiscal quarter and equivalent to approximately 61% of total revenue.

Net Income and Earnings Per Share

The Company's GAAP net income for the second quarter of fiscal 2021 was $119.1 million, or $0.91 per diluted share, compared to GAAP net income of $127.0 million, or $0.94 per diluted share, in the prior fiscal years second quarter. Net income on a non-GAAP basis was $148.1 million, or $1.13 per diluted share, compared to non-GAAP net income of $145.7 million, or $1.08 per diluted share, in the second quarter of fiscal 2020. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, equity-based compensation expenses, and other, net of related tax effects, in the second quarter of fiscal 2021 as well as in the second quarter of fiscal 2020.

For further details of reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.

Returning Cash to Shareholders

-- Quarterly Cash Dividend Program: On May 12, 2021, the Board approved the Companys next quarterly cash dividend payment of $0.36 per share and set June 30, 2021 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on July 23, 2021. -- Share Repurchase Activity: Repurchased a record $360 million of ordinary shares during the second quarter of fiscal 2021, including the return of the net proceeds from the divestiture of OpenMarket. The board of directors has approved a share repurchase plan authorizing the repurchase of up to $1 billion of ordinary shares at the companys discretion; this plan has no expiration date and is in addition to the current authorization, which, as of March 31, 2021, provided for up to $228 million of remaining repurchase authorization. Between the two authorizations, we have up to $1.228 billion of remaining repurchase authority.

Twelve-month BacklogTwelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $3.54 billion (excluding OpenMarket) at the end of the second quarter of fiscal 2021. On a pro forma(2) basis, twelve-month backlog was up approximately 9.3% as compared to last years second fiscal quarter.

ThirdQuarter Fiscal 2021 Outlook

-- Revenue of approximately $1,040-$1,080 million, assuming approximately $3 million sequential negative impact from foreign currency fluctuations as compared to the second quarter of fiscal 2021 and contributions from recently completed acquisitions -- GAAP diluted EPS of approximately $0.91-$0.99. The impact of recent acquisitions on GAAP diluted EPS will not be known until after Amdocs completes the purchase price allocation -- Non-GAAP diluted EPS of approximately $1.14-$1.20, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, and approximately $0.08-$0.10 per share of equity-based compensation expense, net of related tax effects.

Full Year Fiscal 2021 Outlook

-- Full year fiscal 2021 revenue guidance reflects the divestiture of OpenMarket as of December 31, 2020 and incorporates an expected positive impact from foreign currency fluctuations of about 1.0% year-over-year as compared with a positive impact of about 1.2% year-over-year previously and a positive contribution from recently completed acquisitions of about 0.5% -- Expects pro forma(2) revenue growth of 5.0%-8.0% year-over-year on a constant currency basis as compared with 3.5%-7.5% year-over-year on a constant currency basis previously -- Expects revenue growth of 1.0%-4.0% year-over-year on a reported basis as compared with (0.3)% -3.7% year-over-year previously -- Expects revenue growth of 0.0%-3.0% year-over-year on a constant currency basis as compared with (1.5)% -2.5% year-over-year previously -- Expects GAAP diluted earnings per share growth of roughly 39.0%-44.0% year-over-year, including gain, net of tax, from divestiture of OpenMarket, as compared with 37.5%-44.5% year-over-year previously. The impact of recent acquisitions on GAAP diluted EPS will not be known until after Amdocs completes the purchase price allocation -- Expects non-GAAP diluted earnings per share growth of roughly 6.0%-9.0% year-over-year as compared with 4.0%-8.0% year-over-year previously, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, approximately $0.32-$0.36 per share of equity-based compensation expense, and gain from divestiture of OpenMarket, net of related tax effects. The impact of recent acquisitions on Amdocs non-GAAP diluted earnings per share is expected to be neutral in the full fiscal year 2021 -- Expects pro forma(2) non-GAAP diluted earnings per share growth of roughly 7.5%-10.5% year-over-year as compared with 5.5%-9.5% year-over-year previously, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, approximately $0.32-$0.36 per share of equity-based compensation expense, and gain from divestiture of OpenMarket, net of related tax effects -- Expects free cash flow of approximately $620 million, comprised of cash flow from operations, less net capital expenditures and other, as compared with $600 million previously -- Expects normalized free cash flow of approximately $820 million as compared with $800 million previously; normalized free cash flow excludes expected capital expenditure of $140 million related to the new campus development in Israel, $40 million of capital gains tax in relation to the divestiture of OpenMarket, and other items

Our third fiscal quarter 2021 and full year fiscal 2021 outlook takes into consideration the Companys current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call.However, we note thatmarket dynamics continue to shift rapidly and wecannot predict all possible outcomes, including those resulting from the COVID-19 pandemic, which has created, and continues to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.

Conference Call Details Amdocs will host a conference call on May 12, 2021 at 5:00 p.m. Eastern Time to discuss the Company's second quarter of fiscal 2021 results. To participate, please dial +1 (844) 513-7152, or +1 (508) 637-5600 outside the United States, approximately 15 minutes before the call and enter passcode 3504547. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial MeasuresThis release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:

-- amortization of purchased intangible assets and other acquisition-related costs; -- changes in certain acquisition-related liabilities measured at fair value; -- non-recurring and unusual charges or benefits (such as a gain from divestiture of OpenMarket); -- equity-based compensation expense; -- other; and -- tax effects related to the above.

Free cash flow equals cash generated by operating activities less net capital expenditures and other. Normalized free cash flow, a measure of our operating performance, is further adjusted to exclude net capital expenditures related to the new campus development, payments for non-recurring and unusual charges (such as capital gains tax in relation to the divestiture of OpenMarket), and payments of acquisition related liabilities. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs,changes in certain acquisition-related liabilitiesmeasured at fair value, non-recurring and unusual charges or benefits, equity-based compensation expense, other and related tax effects. Amdocs management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

Supporting Resources

-- Keep up with Amdocs news by visiting the Companys website -- Subscribe to Amdocs RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube

About AmdocsAmdocs purpose is to enrich lives and progress society, using creativity and technology to build a better connected world. Amdocs and its 27,000 employees partner with the leading players in the communications and media industry, enabling next-generation experiences in 85 countries. Our cloud-native, open and dynamic portfolio of digital solutions, platforms and services brings greater choice, faster time to market and flexibility, to better meet the evolving needs of our customers as they drive growth, transform and take their business to the cloud. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $4.2 billion in fiscal 2020.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, the duration and severity of the COVID-19 pandemic, and its impact on the global economy, Amdocs ability to grow in the business markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2020 filed on December 14, 2020 and our Form 6-K furnished for the first quarter of fiscal 2021 on February 16, 2021.

Contact Matthew SmithHead of Investor RelationsAmdocs314-212-8328E-mail: dox_info@amdocs.com

AMDOCS LIMITED

Consolidated Statements of Income(In thousands, except per share data)

Three months ended Six months ended March 31, March 31, 2021^(a) 2020 2021^(a) 2020 Revenue $ 1,048,734 $ 1,047,933 $ 2,135,077 $ 2,089,890 Operating expenses:Cost of 685,515 683,970 1,414,231 1,370,282 revenueResearch and 75,154 68,795 150,823 136,106 developmentSelling,general and 116,951 119,108 238,839 242,575 administrativeAmortizationof purchasedintangible 21,870 19,348 41,740 40,638 assets andother 899,490 891,221 1,845,633 1,789,601 Operating 149,244 156,712 289,444 300,289 income Interest andother expense, (3,542 ) (2,290 ) (10,032 ) (2,642 )netGain from sale - - 226,410 - of a businessIncome before 145,702 154,422 505,822 297,647 income taxes Income taxes 26,635 27,384 87,123 54,677 Net income $ 119,067 $ 127,038 $ 418,699 $ 242,970 Basic earnings $ 0.92 $ 0.95 $ 3.21 $ 1.81 per shareDilutedearnings per $ 0.91 $ 0.94 $ 3.19 $ 1.80 shareBasic weightedaverage number 129,774 134,288 130,457 134,443 of sharesoutstandingDilutedweightedaverage number 130,696 135,059 131,147 135,339 of sharesoutstandingCash dividendsdeclared per $ 0.36 $ 0.3275 $ 0.6875 $ 0.6125 share

AMDOCS LIMITEDSelected Financial Metrics(In thousands, except per share data)

Three months ended Six months ended March 31, March 31, 2021^(a) 2020 2021^(a) 2020 Revenue $ 1,048,734 $ 1,047,933 $ 2,135,077 $ 2,089,890 Non-GAAPoperating 184,883 180,524 372,864 358,464income Non-GAAP net 148,095 145,689 301,067 289,844income Non-GAAPdiluted $ 1.13 $ 1.08 $ 2.30 $ 2.14earnings pershare Dilutedweightedaverage number 130,696 135,059 131,147 135,339of sharesoutstanding

Free Cash Flows and Normalized Free Cash Flow(In thousands)

Three months ended Six months ended March 31, March 31, 2021 2020 2021 2020 Net CashProvided byOperating $ 119,736 $ 102,868 $ 536,221 $ 266,776 Activities^(a) Purchases ofproperty and (49,245 ) (46,170 ) (99,310 ) (104,705 )equipment,net ^(c) Free Cash 70,491 56,698 436,911 162,071 Flow Tax paymenton sale of 25,190 - 25,190 - business^(b) Payments ofacquisition 13,234 1,750 13,234 1,750 relatedliabilities Payments forpreviouslyexpensed - 129 - 1,645 restructuringcharges Net capitalexpendituresrelated to 24,221 17,355 42,555 31,292 the newcampusdevelopment NormalizedFree Cash $ 133,136 $ 75,932 $ 517,890 $ 196,758 Flow

(a) Since January 1, 2021, OpenMarket results are not included in the Consolidated Statements of Income given its divestiture.(b) Tax payment related to capital gain from divesture of OpenMarket, which was completed on December 31, 2020.(c) The amounts under "Purchase of property and equipment, net include proceeds from sale of property and equipment of $136 and $82 for the six months ended March 31, 2021 and 2020, respectively.

AMDOCS LIMITEDReconciliation of Selected Financial Metrics from GAAP to Non-GAAP(In thousands)

Three months ended March 31, 2021^(a) Reconciliation items Changes in Amortization certain of purchased Equity based acquisitions Tax GAAP intangible compensation related Other effect Non-GAAP assets and expense liabilities other measured at fair valueOperating expenses: Cost of revenue $ 685,515 $ - $ (5,582 ) $ (394 ) $ - $ - $ 679,539 Research 75,154 - (1,012 ) - - - 74,142 anddevelopmentSelling, general 116,951 - (6,781 ) - - - 110,170 andadministrativeAmortizationofpurchased 21,870 (21,870 ) - - - - - intangible assetsand other Total 899,490 (21,870 ) (13,375 ) (394 ) - - 863,851 operatingexpenses Operating income 149,244 21,870 13,375 394 - - 184,883 Interest and other (3,542 ) - - - (375 ) - (3,917 )expense, net Income taxes 26,635 - - - - 6,236 32,871 Net income $ 119,067 $ 21,870 $ 13,375 $ 394 $ (375 ) $ (6,236 ) $ 148,095

Three months ended March 31, 2020 Reconciliation items Amortization Changes in of Equity based certain purchased compensation acquisitions Tax Non-GAAP GAAP intangible expense related effect assets and liabilities other measured at fair valueOperating expenses: Cost of revenue $ 683,970 $ - $ (4,693 ) $ 6,284 $ - $ 685,561 Research 68,795 - (723 ) - - 68,072 anddevelopmentSelling, general 119,108 - (5,332 ) - - 113,776 andadministrativeAmortizationofpurchased 19,348 (19,348 ) - - - - intangible assetsand otherTotal 891,221 (19,348 ) (10,748 ) 6,284 - 867,409 operatingexpenses Operating income 156,712 19,348 10,748 (6,284 ) - 180,524 Income taxes 27,384 - - - 5,161 32,545 Net income $ 127,038 $ 19,348 $ 10,748 $ (6,284 ) $ (5,161 ) $ 145,689

AMDOCS LIMITEDReconciliation of Selected Financial Metrics from GAAP to Non-GAAP(In thousands)

Six months ended March 31, 2021^(a) Reconciliation items Amortization Changes in of Equity based certain Gain from purchased compensation acquisitions sale of a Tax GAAP intangible expense related business Other effect Non-GAAP assets and liabilities other measured at fair valueOperating expenses: Cost of revenue $ 1,414,231 $ - $ (10,523 ) $ (15,728 ) $ - $ - $ - $ 1,387,980 Research 150,823 - (1,844 ) - - - - 148,979 anddevelopmentSelling, general 238,839 - (13,585 ) - - - - 225,254 andadministrativeAmortizationofpurchased 41,740 (41,740 ) - - - - - - intangible assetsand otherTotal 1,845,633 (41,740 ) (25,952 ) (15,728 ) - - - 1,762,213 operatingexpenses Operating income 289,444 41,740 25,952 15,728 - - - 372,864 Interest and other (10,032 ) - - - - 824 - (9,208 )expense, net Gain from sale of a 226,410 - - - (226,410 ) - - - business Income taxes 87,123 - - - - - (24,534 ) 62,589 Net income $ 418,699 $ 41,740 $ 25,952 $ 15,728 $ (226,410 ) $ 824 $ 24,534 $ 301,067

Six months ended March 31, 2020 Reconciliation items Amortization Changes in of certain purchased Equity based acquisitions Tax GAAP intangible compensation related effect Non-GAAP assets and expense liabilities other measured at fair valueOperating expenses: Cost of revenue $ 1,370,282 $ - $ (10,039 ) $ 3,972 $ - $ 1,364,215Research 136,106 - (1,526 ) - - 134,580anddevelopmentSelling, general 242,575 - (9,944 ) - - 232,631andadministrativeAmortizationofpurchased 40,638 (40,638 ) - - - -intangible assetsand otherTotal 1,789,601 (40,638 ) (21,509 ) 3,972 - 1,731,426operatingexpenses Operating income 300,289 40,638 21,509 (3,972 ) - 358,464 Income taxes 54,677 - - - 11,301 65,978 Net income $ 242,970 $ 40,638 $ 21,509 $ (3,972 ) $ (11,301 ) $ 289,844

AMDOCS LIMITEDCondensed Consolidated Balance Sheets(In thousands)

As of March 31, September 2021 30, 2020 ASSETS Current assets Cash and cash equivalents $ 968,988 $ 983,188Short-term interest-bearing investments 194,684 752Accounts receivable, net, including unbilled of 907,017 861,033$172,301 and $175,548, respectivelyPrepaid expenses and other current assets 227,560 229,604Total current assets 2,298,249 2,074,577 Property and equipment, net 640,253 607,951Lease assets 266,719 295,494Goodwill and other intangible assets, net 2,883,646 2,874,979Other noncurrent assets 513,219 488,620Total assets $ 6,602,086 $ 6,341,621 LIABILITIES AND SHAREHOLDERS? EQUITY Current liabilities Accounts payable, accruals and other $ 961,670 $ 930,259Short-term financing arrangement 100,000 100,000Lease liabilities 58,794 59,100Deferred revenue 219,199 126,841Total current liabilities 1,339,663 1,216,200Lease liabilities 209,276 230,076Long-term debt, net of unamortized debt issuance 644,276 644,023costsOther noncurrent liabilities 762,133 586,167Total Amdocs Limited Shareholders? equity 3,604,229 3,622,646Noncontrolling interests 42,509 42,509Total equity 3,646,738 3,665,155Total liabilities and equity $ 6,602,086 $ 6,341,621

AMDOCS LIMITEDConsolidated Statements of Cash Flows(In thousands)

Six months ended March 31, 2021 2020 Cash Flow from Operating Activities: Net income^(a) $ 418,699 $ 242,970 Reconciliation of net income to net cash provided by operating activities:Depreciation and amortization 101,298 98,107 Amortization of debt issuance costs 272 - Equity-based compensation expense 25,952 21,509 Gain from sale of a business (226,410 ) - Deferred income taxes (27,778 ) 9,150 Loss from short-term interest-bearing 221 - investmentsNet changes in operating assets and liabilities, net of amounts acquired:Accounts receivable, net (108,799 ) 19,957 Prepaid expenses and other current assets (11,906 ) (22,637 )Other noncurrent assets (10,763 ) (1,653 )Lease assets and liabilities, net 7,522 (11,947 )Accounts payable, accrued expenses and 76,427 (96,647 )accrued personnelDeferred revenue 226,904 17,616 Income taxes payable, net 41,629 7,853 Other noncurrent liabilities 22,953 (17,502 )Net cash provided by operating activities 536,221 266,776 Cash Flow from Investing Activities: Purchase of property and equipment, net ^ (99,310 ) (104,705 )(c)Proceeds from sale of short-term 4,258 - interest-bearing investmentsPurchase of short-term interest-bearing (200,088 ) - investmentsNet cash paid for business and intangible (87,600 ) - assets acquisitionsNet cash received from sale of a business 290,789 - Other 562 (3,273 )Net cash used in investing activities (91,389 ) (107,978 ) Cash Flow from Financing Activities: Borrowings under financing arrangements - 350,000 Repurchase of shares (450,074 ) (210,048 )Proceeds from employee stock options 78,438 70,639 exercisesPayments of dividends (85,934 ) (76,770 )Payment of contingent consideration from a (1,462 ) (1,411 )business acquisitionOther - (238 )Net cash (used in) provided by financing (459,032 ) 132,172 activities Net (decrease) increase in cash and cash (14,200 ) 290,970 equivalentsCash and cash equivalents at beginning of 983,188 471,632 periodCash and cash equivalents at end of period $ 968,988 $ 762,602

AMDOCS LIMITEDSupplementary Information(In millions)

Three months ended March31, December31, September30, June30, March31, 2021^(a) 2020 2020 2020 2020North $ 679.1 $ 703.4 $ 681.6 $ 685.9 $ 691.3AmericaEurope 148.8 171.6 165.3 145.4 148.3Rest ofthe 220.8 211.3 206.0 194.9 208.3WorldTotal $ 1,048.7 $ 1,086.3 $ 1,052.9 $ 1,026.2 $ 1,047.9Revenue Three months ended March31, December31, September30, June30, March31, 2021 2020 2020 2020 2020ManagedServices $ 634.6 $ 623.7 $ 610.5 $ 604.5 $ 604.0Revenue As of March31, December31, September30, June30, March31, 2021^(d) 2020^(d) 2020 2020 202012-Month $ 3,540 $ 3,490 $ 3,620 $ 3,480 $ 3,460Backlog

(d) Excludes OpenMarket







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC